87 related articles for article (PubMed ID: 26575121)
1. Serum miR-21 may be a Potential Diagnostic Biomarker for Diabetic Nephropathy.
Wang J; Duan L; Tian L; Liu J; Wang S; Gao Y; Yang J
Exp Clin Endocrinol Diabetes; 2016 Jul; 124(7):417-23. PubMed ID: 26575121
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR-30c promotes renal fibrosis by target CTGF in diabetic nephropathy.
Wang J; Duan L; Guo T; Gao Y; Tian L; Liu J; Wang S; Yang J
J Diabetes Complications; 2016 Apr; 30(3):406-14. PubMed ID: 26775556
[TBL] [Abstract][Full Text] [Related]
3. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
[TBL] [Abstract][Full Text] [Related]
4. Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice.
Wang J; Gao Y; Ma M; Li M; Zou D; Yang J; Zhu Z; Zhao X
Cell Biochem Biophys; 2013 Nov; 67(2):537-46. PubMed ID: 23443810
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor blocker valsartan ameliorates cardiac fibrosis partly by inhibiting miR-21 expression in diabetic nephropathy mice.
Wang J; Duan L; Gao Y; Zhou S; Liu Y; Wei S; An S; Liu J; Tian L; Wang S
Mol Cell Endocrinol; 2018 Sep; 472():149-158. PubMed ID: 29233785
[TBL] [Abstract][Full Text] [Related]
6. Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Xu LP; Zhu ZY; Li JY; Zhou SN; Cui FQ; Zeng XJ; Geng JG; Yang JK
Am J Physiol Renal Physiol; 2014 Mar; 306(5):F486-95. PubMed ID: 24370587
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA (miR)-590-3p alleviates high-glucose induced renal tubular epithelial cell damage by targeting C-X3-C motif chemokine ligand 1 (CX3CL1) in diabetic nephropathy.
Yun J; Ren J; Liu Y; Dai L; Song L; Ma X; Luo S; Song Y
Bioengineered; 2022 Jan; 13(1):634-644. PubMed ID: 34898373
[TBL] [Abstract][Full Text] [Related]
8. miR-30e targets GLIPR-2 to modulate diabetic nephropathy:
Zhao D; Jia J; Shao H
J Mol Endocrinol; 2017 Aug; 59(2):181-190. PubMed ID: 28733476
[TBL] [Abstract][Full Text] [Related]
9. Atrasentan increased the expression of klotho by mediating miR-199b-5p and prevented renal tubular injury in diabetic nephropathy.
Kang WL; Xu GS
Sci Rep; 2016 Jan; 6():19979. PubMed ID: 26813039
[TBL] [Abstract][Full Text] [Related]
10. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.
McClelland AD; Herman-Edelstein M; Komers R; Jha JC; Winbanks CE; Hagiwara S; Gregorevic P; Kantharidis P; Cooper ME
Clin Sci (Lond); 2015 Dec; 129(12):1237-49. PubMed ID: 26415649
[TBL] [Abstract][Full Text] [Related]
11. High glucose induces renal tubular epithelial injury via Sirt1/NF-kappaB/microR-29/Keap1 signal pathway.
Zhou L; Xu DY; Sha WG; Shen L; Lu GY; Yin X; Wang MJ
J Transl Med; 2015 Nov; 13():352. PubMed ID: 26552447
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation.
Rovira-Llopis S; Escribano-Lopez I; Diaz-Morales N; Iannantuoni F; Lopez-Domenech S; Andújar I; Jover A; Pantoja J; Pallardo LM; Bañuls C; Victor VM
Cell Physiol Biochem; 2018; 50(3):1005-1014. PubMed ID: 30355913
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors.
Kato M; Zhang J; Wang M; Lanting L; Yuan H; Rossi JJ; Natarajan R
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3432-7. PubMed ID: 17360662
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice.
Zhang Z; Peng H; Chen J; Chen X; Han F; Xu X; He X; Yan N
FEBS Lett; 2009 Jun; 583(12):2009-14. PubMed ID: 19450585
[TBL] [Abstract][Full Text] [Related]
15. Hyperoside ameliorates glomerulosclerosis in diabetic nephropathy by downregulating miR-21.
Zhang L; He S; Yang F; Yu H; Xie W; Dai Q; Zhang D; Liu X; Zhou S; Zhang K
Can J Physiol Pharmacol; 2016 Dec; 94(12):1249-1256. PubMed ID: 27704873
[TBL] [Abstract][Full Text] [Related]
16. Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis.
Park S; Moon S; Lee K; Park IB; Lee DH; Nam S
Cell Physiol Biochem; 2018; 46(4):1331-1340. PubMed ID: 29689545
[TBL] [Abstract][Full Text] [Related]
17. Xiaokeping mixture inhibits diabetic nephropathy in streptozotocin-induced rats through blocking TGF-β1/Smad7 signaling.
Xin C; Xia Z; Jiang C; Lin M; Li G
Drug Des Devel Ther; 2015; 9():6269-74. PubMed ID: 26664048
[TBL] [Abstract][Full Text] [Related]
18. Curcumin ameliorates Podocytic adhesive capacity damage under mechanical stress by inhibiting miR-124 expression.
Li D; Lu Z; Jia J; Zheng Z; Lin S
Kidney Blood Press Res; 2013; 38(1):61-71. PubMed ID: 24556741
[TBL] [Abstract][Full Text] [Related]
19. The decreased expression of electron transfer flavoprotein β is associated with tubular cell apoptosis in diabetic nephropathy.
Wang H; Zhang H; Chen X; Zhao T; Kong Q; Yan M; Zhang B; Sun S; Lan HY; Li N; Li P
Int J Mol Med; 2016 May; 37(5):1290-8. PubMed ID: 27035869
[TBL] [Abstract][Full Text] [Related]
20. The Inhibitory Effect of Rapamycin on Toll Like Receptor 4 and Interleukin 17 in the Early Stage of Rat Diabetic Nephropathy.
Yu R; Bo H; Villani V; Spencer PJ; Fu P
Kidney Blood Press Res; 2016; 41(1):55-69. PubMed ID: 26849067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
